NEXENTIS TECHNOLOGIES INC. Other Non-Current Assets
NEXENTIS TECHNOLOGIES INC. (NXTS) had Other Non-Current Assets of $2.78 million as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-05-14
- 2026-03-31: Other Assets, Noncurrent $2.78M.
- 2025-12-31: Other Assets, Noncurrent $2.74M.
- 2025-09-30: Other Assets, Noncurrent $1.56M.
- 2025-06-30: Other Assets, Noncurrent $1.63M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2026-03-31 | $2.78M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $2.74M 10-Q · filed 2026-05-14 |
| 2025-09-30 | $1.56M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.63M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.25M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $808.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $788.34K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |